Report Detail

Medical Devices & Consumables Global FPR1 Antibody Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM4612963
  • |
  • 02 September, 2024
  • |
  • Global
  • |
  • 107 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Medical Devices & Consumables

FPR1 antibody is an immunoglobulin directed against FPR1 (Formyl Peptide Receptor 1, N-formyl peptide receptor 1). FPR1 is a G protein-coupled receptor that can recognize and bind chemical substances such as bacterial-derived N-formyl peptide and plays an important role in immune and inflammatory responses. FPR1 antibodies are usually produced by animal immunization and can be used in scientific research to detect, locate and quantify the expression level of FPR1 protein in cells or tissues. The application of this antibody can help researchers better understand the function of FPR1 in biological processes such as inflammation, immune response, cell migration, and its relationship with the occurrence and development of diseases.
According to our (Global Info Research) latest study, the global FPR1 Antibody market size was valued at US$ 59.4 million in 2023 and is forecast to a readjusted size of USD 82.6 million by 2030 with a CAGR of 4.8% during review period.
FPR1(Formyl Peptide Receptor 1)作为G蛋白偶联受体,在炎症反应、细胞迁移和癌症发展中发挥着重要作用。因此,FPR1抗体在科研和临床应用中的需求逐渐增长,特别是在肿瘤学和免疫学领域。随着生物技术的不断进步,FPR1抗体的制备技术也在提高。高亲和力、高特异性的抗体能够更好地满足科研和临床的需求,推动FPR1抗体市场的快速发展。总的来说,FPR1抗体市场具有广阔的发展前景和巨大的市场潜力。
This report is a detailed and comprehensive analysis for global FPR1 Antibody market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global FPR1 Antibody market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global FPR1 Antibody market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global FPR1 Antibody market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global FPR1 Antibody market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for FPR1 Antibody
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global FPR1 Antibody market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abcam, Cell Signaling Technology, Santa Cruz Biotechnology, Novus Biologicals, Thermo Fisher Scientific, R&D Systems, Sigma-Aldrich, BioLegend, OriGene Technologies, Boster Bio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
FPR1 Antibody market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Monoclonal Antibodies
Polyclonal Antibodies
Market segment by Application
Immunology Research
Biomedical Research
Drug Discovery
Major players covered
Abcam
Cell Signaling Technology
Santa Cruz Biotechnology
Novus Biologicals
Thermo Fisher Scientific
R&D Systems
Sigma-Aldrich
BioLegend
OriGene Technologies
Boster Bio
Proteintech
4a Biotech
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe FPR1 Antibody product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of FPR1 Antibody, with price, sales quantity, revenue, and global market share of FPR1 Antibody from 2019 to 2024.
Chapter 3, the FPR1 Antibody competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the FPR1 Antibody breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and FPR1 Antibody market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of FPR1 Antibody.
Chapter 14 and 15, to describe FPR1 Antibody sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global FPR1 Antibody Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Monoclonal Antibodies
    • 1.3.3 Polyclonal Antibodies
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global FPR1 Antibody Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Immunology Research
    • 1.4.3 Biomedical Research
    • 1.4.4 Drug Discovery
  • 1.5 Global FPR1 Antibody Market Size & Forecast
    • 1.5.1 Global FPR1 Antibody Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global FPR1 Antibody Sales Quantity (2019-2030)
    • 1.5.3 Global FPR1 Antibody Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Abcam
    • 2.1.1 Abcam Details
    • 2.1.2 Abcam Major Business
    • 2.1.3 Abcam FPR1 Antibody Product and Services
    • 2.1.4 Abcam FPR1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Abcam Recent Developments/Updates
  • 2.2 Cell Signaling Technology
    • 2.2.1 Cell Signaling Technology Details
    • 2.2.2 Cell Signaling Technology Major Business
    • 2.2.3 Cell Signaling Technology FPR1 Antibody Product and Services
    • 2.2.4 Cell Signaling Technology FPR1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Cell Signaling Technology Recent Developments/Updates
  • 2.3 Santa Cruz Biotechnology
    • 2.3.1 Santa Cruz Biotechnology Details
    • 2.3.2 Santa Cruz Biotechnology Major Business
    • 2.3.3 Santa Cruz Biotechnology FPR1 Antibody Product and Services
    • 2.3.4 Santa Cruz Biotechnology FPR1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Santa Cruz Biotechnology Recent Developments/Updates
  • 2.4 Novus Biologicals
    • 2.4.1 Novus Biologicals Details
    • 2.4.2 Novus Biologicals Major Business
    • 2.4.3 Novus Biologicals FPR1 Antibody Product and Services
    • 2.4.4 Novus Biologicals FPR1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Novus Biologicals Recent Developments/Updates
  • 2.5 Thermo Fisher Scientific
    • 2.5.1 Thermo Fisher Scientific Details
    • 2.5.2 Thermo Fisher Scientific Major Business
    • 2.5.3 Thermo Fisher Scientific FPR1 Antibody Product and Services
    • 2.5.4 Thermo Fisher Scientific FPR1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Thermo Fisher Scientific Recent Developments/Updates
  • 2.6 R&D Systems
    • 2.6.1 R&D Systems Details
    • 2.6.2 R&D Systems Major Business
    • 2.6.3 R&D Systems FPR1 Antibody Product and Services
    • 2.6.4 R&D Systems FPR1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 R&D Systems Recent Developments/Updates
  • 2.7 Sigma-Aldrich
    • 2.7.1 Sigma-Aldrich Details
    • 2.7.2 Sigma-Aldrich Major Business
    • 2.7.3 Sigma-Aldrich FPR1 Antibody Product and Services
    • 2.7.4 Sigma-Aldrich FPR1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Sigma-Aldrich Recent Developments/Updates
  • 2.8 BioLegend
    • 2.8.1 BioLegend Details
    • 2.8.2 BioLegend Major Business
    • 2.8.3 BioLegend FPR1 Antibody Product and Services
    • 2.8.4 BioLegend FPR1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 BioLegend Recent Developments/Updates
  • 2.9 OriGene Technologies
    • 2.9.1 OriGene Technologies Details
    • 2.9.2 OriGene Technologies Major Business
    • 2.9.3 OriGene Technologies FPR1 Antibody Product and Services
    • 2.9.4 OriGene Technologies FPR1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 OriGene Technologies Recent Developments/Updates
  • 2.10 Boster Bio
    • 2.10.1 Boster Bio Details
    • 2.10.2 Boster Bio Major Business
    • 2.10.3 Boster Bio FPR1 Antibody Product and Services
    • 2.10.4 Boster Bio FPR1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Boster Bio Recent Developments/Updates
  • 2.11 Proteintech
    • 2.11.1 Proteintech Details
    • 2.11.2 Proteintech Major Business
    • 2.11.3 Proteintech FPR1 Antibody Product and Services
    • 2.11.4 Proteintech FPR1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Proteintech Recent Developments/Updates
  • 2.12 4a Biotech
    • 2.12.1 4a Biotech Details
    • 2.12.2 4a Biotech Major Business
    • 2.12.3 4a Biotech FPR1 Antibody Product and Services
    • 2.12.4 4a Biotech FPR1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 4a Biotech Recent Developments/Updates

3 Competitive Environment: FPR1 Antibody by Manufacturer

  • 3.1 Global FPR1 Antibody Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global FPR1 Antibody Revenue by Manufacturer (2019-2024)
  • 3.3 Global FPR1 Antibody Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of FPR1 Antibody by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 FPR1 Antibody Manufacturer Market Share in 2023
    • 3.4.3 Top 6 FPR1 Antibody Manufacturer Market Share in 2023
  • 3.5 FPR1 Antibody Market: Overall Company Footprint Analysis
    • 3.5.1 FPR1 Antibody Market: Region Footprint
    • 3.5.2 FPR1 Antibody Market: Company Product Type Footprint
    • 3.5.3 FPR1 Antibody Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global FPR1 Antibody Market Size by Region
    • 4.1.1 Global FPR1 Antibody Sales Quantity by Region (2019-2030)
    • 4.1.2 Global FPR1 Antibody Consumption Value by Region (2019-2030)
    • 4.1.3 Global FPR1 Antibody Average Price by Region (2019-2030)
  • 4.2 North America FPR1 Antibody Consumption Value (2019-2030)
  • 4.3 Europe FPR1 Antibody Consumption Value (2019-2030)
  • 4.4 Asia-Pacific FPR1 Antibody Consumption Value (2019-2030)
  • 4.5 South America FPR1 Antibody Consumption Value (2019-2030)
  • 4.6 Middle East & Africa FPR1 Antibody Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global FPR1 Antibody Sales Quantity by Type (2019-2030)
  • 5.2 Global FPR1 Antibody Consumption Value by Type (2019-2030)
  • 5.3 Global FPR1 Antibody Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global FPR1 Antibody Sales Quantity by Application (2019-2030)
  • 6.2 Global FPR1 Antibody Consumption Value by Application (2019-2030)
  • 6.3 Global FPR1 Antibody Average Price by Application (2019-2030)

7 North America

  • 7.1 North America FPR1 Antibody Sales Quantity by Type (2019-2030)
  • 7.2 North America FPR1 Antibody Sales Quantity by Application (2019-2030)
  • 7.3 North America FPR1 Antibody Market Size by Country
    • 7.3.1 North America FPR1 Antibody Sales Quantity by Country (2019-2030)
    • 7.3.2 North America FPR1 Antibody Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe FPR1 Antibody Sales Quantity by Type (2019-2030)
  • 8.2 Europe FPR1 Antibody Sales Quantity by Application (2019-2030)
  • 8.3 Europe FPR1 Antibody Market Size by Country
    • 8.3.1 Europe FPR1 Antibody Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe FPR1 Antibody Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific FPR1 Antibody Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific FPR1 Antibody Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific FPR1 Antibody Market Size by Region
    • 9.3.1 Asia-Pacific FPR1 Antibody Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific FPR1 Antibody Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America FPR1 Antibody Sales Quantity by Type (2019-2030)
  • 10.2 South America FPR1 Antibody Sales Quantity by Application (2019-2030)
  • 10.3 South America FPR1 Antibody Market Size by Country
    • 10.3.1 South America FPR1 Antibody Sales Quantity by Country (2019-2030)
    • 10.3.2 South America FPR1 Antibody Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa FPR1 Antibody Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa FPR1 Antibody Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa FPR1 Antibody Market Size by Country
    • 11.3.1 Middle East & Africa FPR1 Antibody Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa FPR1 Antibody Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 FPR1 Antibody Market Drivers
  • 12.2 FPR1 Antibody Market Restraints
  • 12.3 FPR1 Antibody Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of FPR1 Antibody and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of FPR1 Antibody
  • 13.3 FPR1 Antibody Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 FPR1 Antibody Typical Distributors
  • 14.3 FPR1 Antibody Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on FPR1 Antibody. Industry analysis & Market Report on FPR1 Antibody is a syndicated market report, published as Global FPR1 Antibody Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of FPR1 Antibody market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,641.32
    3,961.98
    5,282.64
    3,128.52
    4,692.78
    6,257.04
    492,802.80
    739,204.20
    985,605.60
    291,728.40
    437,592.60
    583,456.80
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report